PlainRecalls
FDA Drug Moderate Class II Terminated

Testosterone Gel 1% (25mg testosterone/2.5g of gel) 2.5 g per unit dose, Rx Only, 30 unit-dose packets per box. Manufactured by: Actavis Laboratories UT, Inc., Salt Lake City, US 84108, USA, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, USA, Sachet NDC 0591-3216-17, Carton NDC 0591-3216-30

Reported: August 3, 2022 Initiated: June 29, 2022 #D-1289-2022

Product Description

Testosterone Gel 1% (25mg testosterone/2.5g of gel) 2.5 g per unit dose, Rx Only, 30 unit-dose packets per box. Manufactured by: Actavis Laboratories UT, Inc., Salt Lake City, US 84108, USA, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, USA, Sachet NDC 0591-3216-17, Carton NDC 0591-3216-30

Reason for Recall

Superpotent Drug: Out of specification assay result was obtained during stability testing.

Details

Units Affected
12354 cartons
Distribution
Nationwide in the USA
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Testosterone Gel 1% (25mg testosterone/2.5g of gel) 2.5 g per unit dose, Rx Only, 30 unit-dose packets per box. Manufactured by: Actavis Laboratories UT, Inc., Salt Lake City, US 84108, USA, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, USA, Sachet NDC 0591-3216-17, Carton NDC 0591-3216-30. Recalled by Teva Pharmaceuticals USA Inc. Units affected: 12354 cartons.
Why was this product recalled?
Superpotent Drug: Out of specification assay result was obtained during stability testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 3, 2022. Severity: Moderate. Recall number: D-1289-2022.